21 studies, 695 men: bariatric surgery improved IIEF-5 scores by 6.45 points and raised total testosterone, but free testosterone didn't move
Journal: Frontiers in Endocrinology | Published: 2026-03-25 | Type: Systematic Review, Meta-Analysis | PMID: 41958883 Authors: Qin Zhongjian et al. (Beijing University of Chinese Medicine; China-Japan Friendship Hospital, Beijing) Funding/COI: Funding not reported. Authors declared no commercial or financial conflicts of interest.
Bariatric surgery — sleeve gastrectomy, Roux-en-Y gastric bypass, adjustable banding, or biliopancreatic diversion — was associated with significant improvements in erectile function and sexual satisfaction in obese men across 21 studies totaling 695 participants. Total testosterone rose substantially (MD = 8.21 nmol/L, p < 0.001), but free testosterone showed no significant change, likely because surgery also elevates SHBG. The evidence base is dominated by before-after observational studies without control groups, and only one RCT made the inclusion cut.
This is a competently executed meta-analysis on its own terms: PRISMA-compliant, PROSPERO-registered, four databases searched with grey literature, random-effects model applied throughout, subgroup and sensitivity analyses performed, and Egger's test returned negative for publication bias. Quality assessments via NOS rated 16 of 21 studies as high quality and 5 as moderate.
The fundamental problem isn't the meta-analytic methodology — it's what got pooled. Twenty of 21 included studies are observational or before-after designs without control groups. That means every reported improvement could reflect regression to the mean, lifestyle change, weight loss independent of the surgical mechanism, or the simple attention effect of participating in a bariatric program. Heterogeneity is substantial across nearly every outcome (I² ranging from 64.8% to 91.2%), signaling that these studies differ in population, surgical technique, follow-up duration, and outcome measurement in ways that make pooled estimates difficult to interpret clinically. Median follow-up of 12 months provides no evidence on durability.
This meta-analysis joins a consistent signal in the literature: bariatric surgery is associated with better erectile function and higher total testosterone in obese men, and the effect sizes are not trivial — a 6.45-point IIEF-5 improvement is clinically meaningful. But "associated" is carrying enormous weight here. Twenty of 21 studies lack a control group, the entire pooled sample is under 700 men, and heterogeneity is high enough across outcomes to question whether a single pooled estimate is informative. The most interesting finding in the paper — total testosterone rises while free testosterone doesn't, suggesting SHBG mediation — is underanalyzed. This is a well-run synthesis of a weak evidence base. Useful for framing future RCT hypotheses; insufficient to attribute the observed improvements to surgery itself rather than the accompanying weight loss or lifestyle change.